Plasma free N-terminal fibronectin 30-kDa domain as a marker of endothelial dysfunction in type 1 diabetes mellitus

Eur J Clin Invest. 1990 Apr;20(2):171-6. doi: 10.1111/j.1365-2362.1990.tb02265.x.

Abstract

The plasma free N-terminal fibronectin 30-kDa domain was measured in 44 type 1 diabetic patients and in 20 healthy subjects. A significantly raised mean concentration of a free N-terminal fibronectin 30-kDa domain was found in plasma of diabetic patients with proliferative retinopathy as compared with healthy persons (P less than 0.001). A positive correlation was observed between free N-terminal fibronectin 30-kDa domain and von Willebrand factor in plasma of all examined subjects (r = 0.62, P less than 0.01). A similar correlation was present between 30-kDa domain and albuminuria (r = 0.56, P less than 0.01). However, no relationship was found between fibronectin 30-kDa domain and control of diabetes as assessed by fructosamine concentration. The free N-terminal fibronectin 30-kDa domain may be used as a marker of actual endothelial cell dysfunction in diabetes.

MeSH terms

  • Adult
  • Biomarkers / blood
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetic Angiopathies / blood
  • Diabetic Retinopathy / blood
  • Endothelium, Vascular / metabolism
  • Female
  • Fibronectins / blood*
  • Humans
  • Male
  • Middle Aged
  • Molecular Weight
  • Peptide Fragments / blood*

Substances

  • Biomarkers
  • Fibronectins
  • Peptide Fragments